Document Detail


Anti-Glutamic Acid Decarboxylase Limbic Encephalitis Without Epilepsy Evolving Into Dementia With Cerebellar Ataxia.
MedLine Citation:
PMID:  22507885     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: To expand the spectrum of the clinical presentation of anti-glutamic acid decarboxylase antibodies-related limbic encephalitis and to improve the recognition of this entity. DESIGN: Case study. SETTING: University hospital. Patient  An 11-year-old-girl with progressive mood and behavioral disorder, speech impairment, and short-term memory impairment who manifested cerebellar ataxia with nystagmus during the disease course. INTERVENTIONS: Blood and cerebrospinal fluid analysis including autoantibodies, electroencephalography, brain and spinal magnetic resonance imaging, and cognitive and neuropsychological assessment were performed. High-dose methylprednisolone sodium succinate pulses, cycles of intravenous immunoglobulins, mycophenolate mofetil, and rituximab as well as antipsychotics and benzodiazepine were administered. RESULTS: Diagnosis of anti-glutamic acid decarboxylase antibodies-related limbic encephalitis was made. The clinical features during the first months of disease included only mood, behavioral, and memory impairment. After 5 months, despite immunotherapies, cerebellar ataxia with nystagmus appeared with brain magnetic resonance imaging evidence of cerebral atrophy. No clinical or infraclinical seizures were recorded during follow-up. CONCLUSIONS: Anti-glutamic acid decarboxylase antibodies-related limbic encephalitis can present with only behavioral or neuropsychological symptoms without any epileptic disorder. Moreover, cerebellar ataxia related to anti-glutamic acid decarboxylase antibodies can be observed in patients with limbic encephalitis during the disease course.
Authors:
Marisol Mirabelli-Badenier; Giovanni Morana; Francesca Pinto; Antonio Uccelli; Edvige Veneselli; Francesca Maria Battaglia; Roberta Biancheri; Maria Giuseppina Baglietto; Angela Vincent; Maria Margherita Mancardi
Related Documents :
6588265 - Supplements containing amino acids and keto acids in the treatment of chronic uremia.
2193535 - Effect of epinephrine on amino acid and energy metabolism in humans.
696265 - Amino acid transport in human ciliary epithelium.
10816435 - Increased translation efficiency and antizyme-dependent stabilization of ornithine deca...
9458275 - Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia.
9491765 - Trypanocidal effects of gallic acid and related compounds.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-16
Journal Detail:
Title:  Archives of neurology     Volume:  -     ISSN:  1538-3687     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Pinto, Veneselli, Battaglia, Biancheri, Baglietto, and Mancardi) and Pediatric Neuroradiology (Dr Morana), Giannina Gaslini Institute, and Department of Neuroscience, Ophthalmology, and Genetics, University of Genoa and Advanced Biotechnology Center (Dr Uccelli), Genoa, Italy; and Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England (Dr Vincent).
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of ?-Aminobutyric AcidBReceptor-Antibody Autoimmune Encephalitis With Oral Corticosteroids...
Next Document:  ?-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study): A Randomized, Double-Blind, Placebo-Co...